Catalyst Wire Dossier Catalyst Wire Dossier

GMCI

· Candel Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GMCI, covering 2025-02-14 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas [Phase 1]

See pricing